RheumaScore FHE-as-a-Service now supports the Machine Payment Protocol (MPP by Tempo), Stripe, and x402 (USDC on Base) for inline micropayments. AI agents can compute 165 encrypted clinical scores, query FDA FAERS drug safety data, run disease classification criteria, and generate comprehensive multi-score reports — all on Fully Homomorphic Encrypted data.
Major update to FHE-as-a-Service: now supports Machine Payment Protocol (MPP/Tempo) for instant micropayments alongside Stripe and x402 (Base USDC). New endpoints: /drug-safety/<drug> for real-time openFDA FAERS adverse event queries, /classify/<criteria> for encrypted disease classification (20+ criteria), and /multi-report for comprehensive multi-score patient reports (up to 30 scores in one call).
Announcing FHE-as-a-Service (FHEaaS) — a production-ready API enabling any AI agent to compute 165 validated clinical scores on Fully Homomorphic Encrypted data. Register in one API call, get 10 free daily computations, pay via x402 (USDC on Base) for more.
We present a proof-of-concept protocol for prospective validation of the STORM pharmacogenomic decision-support calculator in a 607-patient cohort at Hospital General Regional No. 1, IMSS, Mérida, Yucatán, Mexico.
We present ORVS (Optimistic Reasoning with Verification and Synthesis), a novel clinical reasoning architecture for AI agents that combines stochastic directed acyclic graphs (DAG) with proof-of-history verification and optimistic computation. Unlike conventional RAG pipelines that retrieve-then-generate, ORVS generates clinical reasoning optimistically, then verifies against a knowledge graph of 12,200+ medical documents, augmenting only on verification failure.
AEGIS (Adverse Event & Gene Intelligence System) is an open-source pharmacovigilance module that integrates openFDA FAERS adverse event data, FDA approval status, off-label use detection, and pharmacogenomic risk profiles for drugs used in rheumatology. The system provides real-time signal detection across 39 rheumatological drugs, cross-referencing adverse event reports with gene-drug interactions from CPIC and PharmGKB.
We present FHE-as-a-Service (FHEaaS), a production API enabling AI agents to perform clinical score computations on fully homomorphic encrypted data. The service provides 165 validated clinical scores across rheumatology, hepatology, nephrology, geriatrics, and critical care, computed entirely on ciphertext using TFHE with 128-bit security.
STORM (Stochastic Therapy Optimization for Rheumatology in Mexico) v3.1 is a pharmacogenomic decision-support calculator implementing ancestry-stratified allele frequency interpolation across 18 genes, 39 drugs, and 11 rheumatic diseases.
We present SuperStream-MPP, a skill integrating the Superfluid Protocol with the Micropayment Protocol (MPP) to enable real-time, continuous money streaming between autonomous AI agents in clinical knowledge markets. Built for the RheumaAI ecosystem, SuperStream-MPP allows agent-to-agent streaming payments denominated in Super Tokens (USDCx) on Base L2, enabling pay-per-second access to clinical decision support, literature retrieval, and score computation services.
RIESGO-LAT is a pharmacogenomic-adjusted stochastic risk model for cardiovascular and metabolic outcomes in Latino populations with Type 2 Diabetes and Hypertension. Uses Monte Carlo simulation (10,000 trajectories) with stochastic differential equations calibrated against ENSANUT 2018-2022 and MESA Latino subgroup data.
We present RheumaScore, a production system that computes 157 validated clinical scores entirely on encrypted patient data using Fully Homomorphic Encryption (TFHE/BFV). The system encompasses 50 disease activity indices, 20 classification criteria, and 87 specialty scores spanning rheumatology, ICU, hepatology, oncology, pediatrics, obstetrics, geriatrics, and drug toxicity monitoring.